Document is current
Any future updates will be listed below
-
Authors
Nicola, Teodora
Wenger, Nancy
Xu, Xin
Evans, Michael
Qiao, Luhua
Rezonzew, Gabriel
Yang, Youfeng
Jilling, Tamas
Margaroli, Camilla http://orcid.org/0000-0003-3952-0778
Genschmer, Kristopher http://orcid.org/0000-0002-1836-9522
Willis, Kent http://orcid.org/0000-0001-7338-0399
Ambalavanan, Namasivayam http://orcid.org/0000-0003-0731-9092
Blalock, J. Edwin
Gaggar, Amit
Lal, Charitharth Vivek
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K08 HL141652, R35HL135710, R35HL166433, R01HL156275, R44HL164156)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- License Information
-
More Information
Article History
Received: 16 April 2024
Accepted: 31 July 2024
First Online: 19 August 2024
Competing interests
: Part of the research described in this manuscript is patented under “Inhaled Respiratory Probiotics for Lung Diseases of Infancy, Childhood and Adulthood” US 11,141,443 B2 held under the University of Alabama at Birmingham Research Foundation (CL, AG, NA are inventors). The remaining authors declare no competing interests.
